Alice M Jenh

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. doi request reprint Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B
    Alice M Jenh
    Department of Pharmacy, The Johns Hopkins Hospital, 600 North Wolfe St, Carnegie 180, Baltimore, MD 21287, USA
    Expert Rev Anti Infect Ther 8:1079-92. 2010
  2. doi request reprint Severe prolonged sedation associated with coadministration of protease inhibitors and intravenous midazolam during bronchoscopy
    Alice Jenh Hsu
    Department of Pharmacy, The Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Pharmacotherapy 32:538-45. 2012
  3. doi request reprint Tenofovir for the treatment of hepatitis B virus
    Alice M Jenh
    Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Pharmacotherapy 29:1212-27. 2009

Collaborators

Detail Information

Publications3

  1. doi request reprint Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B
    Alice M Jenh
    Department of Pharmacy, The Johns Hopkins Hospital, 600 North Wolfe St, Carnegie 180, Baltimore, MD 21287, USA
    Expert Rev Anti Infect Ther 8:1079-92. 2010
    ..Additionally, tenofovir monotherapy or in combination with nucleoside analogs are options for patients who have developed resistance to other CHB therapies including lamivudine and adefovir...
  2. doi request reprint Severe prolonged sedation associated with coadministration of protease inhibitors and intravenous midazolam during bronchoscopy
    Alice Jenh Hsu
    Department of Pharmacy, The Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Pharmacotherapy 32:538-45. 2012
    ....
  3. doi request reprint Tenofovir for the treatment of hepatitis B virus
    Alice M Jenh
    Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Pharmacotherapy 29:1212-27. 2009
    ..In addition, tenofovir monotherapy or in combination with nucleoside analogs are options for patients who have developed resistance to other therapies for chronic HBV, including lamivudine and adefovir...